José Yélamos
- Oncology top 2%
- Molecular Biology top 5%
- Immunology top 2%
- Surgery top 10%
- Epidemiology top 10%
- Co-authors
- Françoise DantzerValérie SchreiberPascual ParrillaCoral AmpurdanésJuan Martín‐CaballeroRubén MotaLaura LlacunaSaïd Aoufouchi
- Topics
- PARP inhibition in cancer therapy (42 papers)DNA Repair Mechanisms (18 papers)Cell death mechanisms and regulation (17 papers)
- Cited by
- TransplantationOncologyImmunology
- Partner nations
- SpainFranceUnited Kingdom
In The Last Decade
José Yélamos
100 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 110
- Oncology 1.4k
- Molecular Biology 1.4k
- Immunology 1.1k
- Surgery 345
- Epidemiology 322
Countries citing papers authored by José Yélamos
This map shows the geographic impact of José Yélamos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Yélamos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Yélamos more than expected).
Fields of papers citing papers by José Yélamos
This network shows the impact of papers produced by José Yélamos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Yélamos. The network helps show where José Yélamos may publish in the future.
Co-authorship network of co-authors of José Yélamos
This figure shows the co-authorship network connecting the top 25 collaborators of José Yélamos. A scholar is included among the top collaborators of José Yélamos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Yélamos. José Yélamos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 16 | |
| 7 | 9 | |
| 8 | 24 | |
| 9 | 8 | |
| 10 | 19 | |
| 11 | 12 | |
| 12 | 48 | |
| 13 | 9 | |
| 14 | 53 | |
| 15 | Understanding specific functions of PARP-2: new lessons for cancer therapy. | 39 |
| 16 | 22 | |
| 17 | 115 | |
| 18 | 25 | |
| 19 | 3 | |
| 20 | 0 |
About José Yélamos
José Yélamos is a scholar working on Transplantation, Immunology and Oncology, having authored 108 papers that have together received 3.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (42 papers), DNA Repair Mechanisms (18 papers) and Cell death mechanisms and regulation (17 papers). The work is most often cited by research in Transplantation (160 citations), Oncology (1.4k citations) and Immunology (1.1k citations). José Yélamos has collaborated with scholars based in Spain, France and United Kingdom. Frequent co-authors include Françoise Dantzer, Valérie Schreiber, Pascual Parrilla, Coral Ampurdanés, Juan Martín‐Caballero, Rubén Mota, Laura Llacuna, Saïd Aoufouchi, César Milstein and C. Milstein. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.